Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3259 studies found for:    "Bacterial Infections"
Show Display Options
Download search resultsDownload the search results for:
"Bacterial Infections" (3259 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed Retrospective Examination of Initial Care of Severe Bacterial Infections of the Child
Condition: Bacterial Infection
Intervention: Other: Retrospective examination by experts whether care given fo child admitted at the ICU for suspicion of bacterial infection (not nosocomial) was optimal or not
2 Completed Value for Cord Blood Procalcitonin to Diagnose Early Neonatal Bacterial Infection
Condition: Neonatal Bacterial Infection
Intervention: Biological: dosage of the umbilical cord blood Procalcitonin for diagnosing of IBNP
3 Recruiting Study Evaluate the PK Profile of Dalbavancin in Hospitalized Infants and Neonates Patients With Known or Suspected Bacterial Infection
Condition: Bacterial Infections
Intervention: Drug: Dalbavancin
4 Not yet recruiting Exposure to NSAIDs (Non Steroidal Anti-Inflammatory Drugs) and Severity of Community-acquired Bacterial Infections
Condition: Bacterial Infection
Intervention:
5 Unknown  Experimental Phage Therapy of Bacterial Infections
Condition: Bacterial Infections
Intervention: Other: Bacteriophage preparation
6 Recruiting Assessment of the Efficacy of FOSFOMYCIN in Patients With Bacterial Infection
Condition: Bacterial Infection
Intervention:
7 Active, not recruiting The Value of the Neutrophil to Lymphocyte Ratio in the Diagnosis of Bacterial Infections
Condition: Bacterial Infections
Intervention: Biological: neutrophil to lymphocyte ratio
8 Recruiting Dose-finding, Pharmacokinetics, Safety, and Tolerability of Meropenem-Vaborbactam in Pediatric Subjects With Serious Bacterial Infections
Condition: Bacterial Infections
Intervention: Drug: Carbavance
9 Completed Study Of Dalbavancin Drug Levels Achieved In Hospitalized Adolescents Who Are Receiving Antibiotic Therapy For Bacterial Infections
Condition: Bacterial Infections
Intervention: Drug: Dalbavancin
10 Recruiting Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium + Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013)
Condition: Bacterial Infections
Interventions: Drug: Imipenem+Cilastatin/Relebactam;   Drug: Colistimethate sodium (CMS);   Drug: Imipenem+Cilastatin;   Drug: Placebo to CMS
11 Recruiting Open-Label, Dose-Finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Patients With Suspected or Confirmed Bacterial Infections
Condition: Gram Positive Bacterial Infections
Intervention: Drug: Oritavancin
12 Completed Procalcitonin for Predicting Serious Bacterial Infection in Infants Less Than 3 Months
Conditions: Fever;   Bacterial Infection
Intervention:
13 Recruiting Fever and Shivering: Frequency and Role in Predicting Serious Bacterial Infection
Conditions: Febrile Shivering;   Severe Bacterial Infection
Intervention: Other: Ancillary tests
14 Unknown  The Rate of C-reactive Protein (CRP) Increase as a Marker for Bacterial Infections in Children
Conditions: Bacterial Infections;   Viral Infection
Intervention:
15 Completed Pharmacokinetics and Safety of Solithromycin Capsules in Adolescents
Condition: Bacterial Infections
Intervention: Drug: Solithromycin
16 Completed Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Condition: Bacterial Infection
Intervention: Drug: solithromycin
17 Completed A Single Dose Study To Investigate The Pharmacokinetics and Safety Of Dalbavancin In Hospitalized Children Aged 3 Months to 11 Years.
Condition: Bacterial Infections.
Intervention: Drug: Dalbavancin
18 Completed Study Evaluating Antibiotic Utilization Measures and Control of Extended-Spectrum-Lactamases (ESBLs)
Condition: Bacterial Infection
Intervention: Drug: Extended-Spectrum-Lactamases (ESBLs)
19 Completed Increase in Procalcitonin Kinetics May be a Good Indicator of Starting Empirical Antibiotic Treatment in Critically Ill Patients
Condition: Bacterial Infection
Intervention:
20 Recruiting A Study of Oral and Intravenous (IV) Tedizolid Phosphate in Hospitalized Participants, Ages 2 to <12 Years, With Confirmed or Suspected Bacterial Infection (MK-1986-013)
Condition: Gram-Positive Bacterial Infections
Interventions: Drug: Tedizolid Phosphate (IV);   Drug: Tedizolid Phosphate (oral suspension)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.